Lorcaserin

I-CMOAPI inezinhlobonhlobo zemikhiqizo eluhlaza ye-lorcaserin, futhi inesistimu yokuphathwa kwekhwalithi ephelele .Kwadlula isitifiketi se-GMP kanye ne-DMF.

Ibonisa 1-3 yemiphumela engu-6

1 2

Ungayitholaphi i-Lorcaserin kanye nabaPhakathi bayo?

Ungenza i-lorcaserin ithenge ezitolo eziku-inthanethi. Impuphu iyatholakala ngobuningi kubacwaningi nabahlaziyi. Lapho umgomo wakho ukulahla amakhilogremu angeziwe ngenxa yokukhuluphala, ungabheka i-lorcaserin ethengiswa online. Kodwa-ke, ungahle udinge incwadi kadokotela ngenxa yemihlahlandlela eqinile ye-FDA.
Uma ufuna i-lorcaserin noma abaphakathi kwayo, kufanele ubheke ne-CMOAPI ukuthola ukutholakala okuvumelekile kwemikhiqizo emsulwa. Izinhlanganisela zethu zithole isiqinisekiso sekhwalithi.


I-Lorcaserin-Infographic-01 I-Lorcaserin-Infographic-02 I-Lorcaserin-Infographic-03

I-FAQ yeLorcaserin

Ngiyithatha kanjani i-belviq ukuthola imiphumela emihle?

Gwinya yonke ithebhulethi ekhishwe isikhathi eside futhi ungayiqedi, ungayihlafune, noma uyiphule. Ungathatha iBelviq ngokudla noma ngaphandle kokudla. Kufanele ulahlekelwe okungenani u-5% wesisindo sakho sokuqala phakathi namasonto okuqala ayi-12 wokuthatha iBelviq nokudla ukudla okunekhalori eliphansi.

Ungalahlekelwa isisindo esingakanani nge-belviq?

I-Lorcaserin, esetshenziswa kanye nokudla nokuzivocavoca umzimba, iholela ekunciphiseni kwesisindo okulinganiselwa ku-12.9 lb (5.8 kg) uma kuqhathaniswa ne-5.6 lb (2.5 kg) ne-placebo.

Kufanele uthathe isikhathi esingakanani i-belviq?

Ungathatha iBelviq ngokudla noma ngaphandle kokudla. Kufanele ulahlekelwe okungenani u-5% wesisindo sakho sokuqala phakathi namasonto okuqala ayi-12 wokuthatha iBelviq nokudla ukudla okunekhalori eliphansi. Shayela udokotela wakho uma ungalahli okungenani u-5% wesisindo sakho sokuqala ngemuva kokuthatha umuthi amaviki ayi-12.

I-belviq ikwenza uzizwe kanjani?

I-Belviq yaziwa njenge-serotonin 2C receptor agonist ekhethiwe, okusho ukuthi isebenzisa izingxenye ezithile zobuchopho bakho ezikwenza uzizwe ugcwele. Indlala encane iholela ekudleni okuncane, okuholela ekunciphiseni isisindo.

Iyini imiphumela emibi ye-lorcaserin?

Imiphumela emibi ka-Belviq ifaka phakathi: ushukela wegazi ophansi (i-hypoglycemia), izinkinga zengqondo, ukushaya kwenhliziyo okuhamba kancane, ikhanda elibuhlungu, isiyezi, ukozela, ukuzwa ukhathele, ukukhathala,

Ungaphuza utshwala ngenkathi uthatha i-belviq?

Ngabe konke ukuxhumana kwesidakamizwa kuhlangana notshwala? Akuzona zonke izidakamizwa zokwehlisa isisindo ezinokusebenzisana kwezidakamizwa notshwala; isibonelo, i-lorcaserin (i-Belviq, i-Belviq XR) ne-orlistat (i-Alli, i-Xenical) ayikubhalisi ukuhlangana kwezidakamizwa zotshwala ekubhalisweni kwemikhiqizo yabo.

Ingabe i-belviq ingadala ukuzuza kwesisindo?

Imiphumela emincane. Abantu abathatha lesi sidakamizwa unyaka wonke bangalindela ukwehla ngamaphesenti ama-3 kuye kwangama-3.7 wesisindo sabo, futhi bangaphinde babuye babuye nesisindo, ucwaningo lukhombisa. Kokunye ukuhlolwa, iziguli ezithatha iBelviq zilahlekelwe ngamaphesenti ama-5 wesisindo somzimba wazo ngemuva kwezinyanga eziyi-12, kodwa zathola amaphesenti angama-25 azo ekupheleni konyaka wesibili.

Yikuphi okungcono ukuphikisana noma i-belviq?

UBelviq noContrave bangabekilasi lezidakamizwa ezahlukahlukene. I-Belviq iyi-serotonin 2C receptor agonist ne-Contrave iyinhlanganisela ye-opioid antagonist kanye ne-antidepressant.

Ingabe i-belviq iyasebenza ngempela?

Abantu abathatha lesi sidakamizwa unyaka wonke bangalindela ukwehla ngamaphesenti ama-3 kuye kwayi-3.7 kuphela esisindo sabo

Ingabe i-belviq ifana ne-Phentermine?

I-Belviq (i-lorcaserin hydrochloride) ne-Adipex-P (phentermine) isetshenziselwa ukuphatha isisindo ezigulini ezikhuluphele ngaphezu kokudla nokuzivocavoca umzimba. I-Belviq isetshenziselwa ukuphathwa kwesisindo okungapheli.

Ingabe i-belviq inqanyuliwe?

I-US Food and Drug Administration (i-FDA) icele ukuthi umenzi weBelviq, Belviq XR (lorcaserin) ngokuzithandela ahoxise umuthi wokwehlisa isisindo emakethe yase-US.

Okubhekwayo

  1. UTaylor, J., Dietrich, E., noPowell, J. (2013). I-Lorcaserin yokuphathwa kwesisindo. Isifo sikashukela, iMetabolic Syndrome, nokukhuluphala.
  2. Hoy, SM (2013). I-Lorcaserin: Ukubuyekezwa Kwokusetshenziswa Kwayo Ekulawuleni Isisindo Okungapheli. Izidakamizwa.
  3. UHess, R., noCross, LB (2013). Ukuphepha nokusebenza kweLorcaserin ku-Management of Obesity. Imithi Yokuphothula Iziqu.
  4. UBrashier, DB, Sharma, AK, Dahiya, N., noSingh, SK (2014). I-Lorcaserin: I-Novel Antiobesity Izidakamizwa. Ijenali ye-Pharmacology & Pharmacotherapeutics.
  5. UChan, EW et al. (2013). Ukusebenza Nokuphepha kweLorcaserin Kubantu Abakhuluphele ngokweqile: I-Meta-Analysis ye-1-Year Randomized Trials Trials (RCTs) kanye nokuBuyekezwa Okulandelanayo kuma-RCT wesikhathi esifushane. Ukubuyekeza ngokweqile.
  6. INigro, SC, Luon, D., noB Baker, WL (2013). I-Lorcaserin: I-Novel Serotonin 2C Agonist Yokwelapha Ukhuluphele. Ucwaningo Lwanamuhla Lwezokwelapha Nemibono.